These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28435009)

  • 1. Selective small-molecule inhibitors as chemical tools to define the roles of matrix metalloproteinases in disease.
    Meisel JE; Chang M
    Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):2001-2014. PubMed ID: 28435009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.
    Levin M; Udi Y; Solomonov I; Sagi I
    Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seesaw of matrix metalloproteinases (MMPs).
    Kapoor C; Vaidya S; Wadhwan V; ; Kaur G; Pathak A
    J Cancer Res Ther; 2016; 12(1):28-35. PubMed ID: 27072206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential clinical applications of matrix metalloproteinase inhibitors and their future prospects.
    Li W; Saji S; Sato F; Noda M; Toi M
    Int J Biol Markers; 2013 Jun; 28(2):117-30. PubMed ID: 23787494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Matrix Metalloproteinases in the Pathogenesis of Traumatic Brain Injury.
    Abdul-Muneer PM; Pfister BJ; Haorah J; Chandra N
    Mol Neurobiol; 2016 Nov; 53(9):6106-6123. PubMed ID: 26541883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases as therapeutic targets for stroke.
    Yang Y; Rosenberg GA
    Brain Res; 2015 Oct; 1623():30-8. PubMed ID: 25916577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of matrix metalloproteinases and therapeutic benefits of their inhibition in spinal cord injury.
    Zhang H; Chang M; Hansen CN; Basso DM; Noble-Haeusslein LJ
    Neurotherapeutics; 2011 Apr; 8(2):206-20. PubMed ID: 21455784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there new hope for therapeutic matrix metalloproteinase inhibition?
    Vandenbroucke RE; Libert C
    Nat Rev Drug Discov; 2014 Dec; 13(12):904-27. PubMed ID: 25376097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase inhibition in atherosclerosis and stroke.
    Roycik MD; Myers JS; Newcomer RG; Sang QX
    Curr Mol Med; 2013 Sep; 13(8):1299-313. PubMed ID: 23865428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix Metalloproteinases: How Much Can They Do?
    Ågren MS; Auf dem Keller U
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events.
    Noble LJ; Donovan F; Igarashi T; Goussev S; Werb Z
    J Neurosci; 2002 Sep; 22(17):7526-35. PubMed ID: 12196576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs.
    Jabłońska-Trypuć A; Matejczyk M; Rosochacki S
    J Enzyme Inhib Med Chem; 2016; 31(sup1):177-183. PubMed ID: 27028474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Potential of Matrix Metalloproteinase Inhibition in Breast Cancer.
    Radisky ES; Raeeszadeh-Sarmazdeh M; Radisky DC
    J Cell Biochem; 2017 Nov; 118(11):3531-3548. PubMed ID: 28585723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New approaches to selectively target cancer-associated matrix metalloproteinase activity.
    Tauro M; McGuire J; Lynch CC
    Cancer Metastasis Rev; 2014 Dec; 33(4):1043-57. PubMed ID: 25325988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based molecular insights into matrix metalloproteinase inhibitors in cancer treatments.
    Lin H; Xu P; Huang M
    Future Med Chem; 2022 Jan; 14(1):35-51. PubMed ID: 34779649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibiting matrix metalloproteinases, an old story with new potentials for cancer treatment.
    Stellas D; Patsavoudi E
    Anticancer Agents Med Chem; 2012 Sep; 12(7):707-17. PubMed ID: 22292747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinases and their inhibitors in human traumatic spinal cord injury.
    Buss A; Pech K; Kakulas BA; Martin D; Schoenen J; Noth J; Brook GA
    BMC Neurol; 2007 Jun; 7():17. PubMed ID: 17594482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis.
    Curran S; Murray GI
    Eur J Cancer; 2000 Aug; 36(13 Spec No):1621-30. PubMed ID: 10959048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix Metalloproteinases: A challenging paradigm of cancer management.
    Alaseem A; Alhazzani K; Dondapati P; Alobid S; Bishayee A; Rathinavelu A
    Semin Cancer Biol; 2019 Jun; 56():100-115. PubMed ID: 29155240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MMPs in the central nervous system: where the good guys go bad.
    Agrawal SM; Lau L; Yong VW
    Semin Cell Dev Biol; 2008 Feb; 19(1):42-51. PubMed ID: 17646116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.